299 related articles for article (PubMed ID: 19145073)
21. Effect of enalapril treatment on the sensitivity of cardiopulmonary reflexes in rats with myocardial infarction.
Andrade TU; Pinto VD; Medeiros AR; Abreu GR; Moysés MR; Sampaio KN; Bissoli NS
Clin Exp Pharmacol Physiol; 2007 Jul; 34(7):606-11. PubMed ID: 17581216
[TBL] [Abstract][Full Text] [Related]
22. Enalapril improves vascular and cardiac function in streptozotocin-diabetic rats.
Crespo MJ; Dunbar DC
Cell Mol Biol (Noisy-le-grand); 2003 Dec; 49(8):1311-8. PubMed ID: 14984003
[TBL] [Abstract][Full Text] [Related]
23. Effects of sevelamer and calcium-based phosphate binders on mortality in hemodialysis patients: results of a randomized clinical trial.
Suki WN;
J Ren Nutr; 2008 Jan; 18(1):91-8. PubMed ID: 18089452
[TBL] [Abstract][Full Text] [Related]
24. Nonphosphate-binding effects of sevelamer--are they of clinical relevance?
Marangon N; Lindholm B; Stenvinkel P
Semin Dial; 2008; 21(5):385-9. PubMed ID: 18573137
[TBL] [Abstract][Full Text] [Related]
25. Combination therapy with angiotensin-converting enzyme inhibitor and oral adsorbent of uremic toxins can delay the appearance of glomerular sclerosis and interstitial fibrosis in established renal failure.
Okada K; Okawa E; Shibahara H; Maruyama T; Maruyama N; Matsumoto K; Takahashi S
Kidney Blood Press Res; 2004; 27(4):218-25. PubMed ID: 15273424
[TBL] [Abstract][Full Text] [Related]
26. Renal haemodynamics and function in weanling rats treated with enalapril from birth.
Guron G
Clin Exp Pharmacol Physiol; 2005 Oct; 32(10):865-70. PubMed ID: 16173949
[TBL] [Abstract][Full Text] [Related]
27. Novel markers of left ventricular hypertrophy in uremia.
Nakamura H; Tokumoto M; Mizobuchi M; Ritter CS; Finch JL; Mukai M; Slatopolsky E
Am J Nephrol; 2010; 31(4):292-302. PubMed ID: 20130393
[TBL] [Abstract][Full Text] [Related]
28. Sevelamer hydrochloride, a phosphate binder, protects against deterioration of renal function in rats with progressive chronic renal insufficiency.
Nagano N; Miyata S; Obana S; Kobayashi N; Fukushima N; Burke SK; Wada M
Nephrol Dial Transplant; 2003 Oct; 18(10):2014-23. PubMed ID: 13679475
[TBL] [Abstract][Full Text] [Related]
29. Role of phosphorus and vitamin D analogs in the pathogenesis of vascular calcification.
Wu-Wong JR; Noonan W; Ma J; Dixon D; Nakane M; Bolin AL; Koch KA; Postl S; Morgan SJ; Reinhart GA
J Pharmacol Exp Ther; 2006 Jul; 318(1):90-8. PubMed ID: 16603671
[TBL] [Abstract][Full Text] [Related]
30. Effect of cross-linked chitosan iron (III) on vascular calcification in uremic rats.
de Castro BBA; do Carmo WB; de Albuquerque Suassuna PG; Carminatti M; Brito JB; Dominguez WV; de Oliveira IB; Jorgetti V; Custodio MR; Sanders-Pinheiro H
Exp Biol Med (Maywood); 2018 May; 243(9):796-802. PubMed ID: 29763365
[TBL] [Abstract][Full Text] [Related]
31. Sevelamer hydrochloride reverses parathyroid gland enlargement via regression of cell hypertrophy but not apoptosis in rats with chronic renal insufficiency.
Nagano N; Miyata S; Abe M; Wakita S; Kobayashi N; Wada M
Nephrol Dial Transplant; 2006 Mar; 21(3):634-43. PubMed ID: 16169864
[TBL] [Abstract][Full Text] [Related]
32. Effects of calcimimetic combined with an angiotensin-converting enzyme inhibitor on uremic cardiomyopathy progression.
Mizobuchi M; Ogata H; Hosaka N; Kumata C; Nakazawa A; Kondo F; Koiwa F; Kinugasa E; Akizawa T
Am J Nephrol; 2011; 34(3):256-67. PubMed ID: 21791922
[TBL] [Abstract][Full Text] [Related]
33. [Renin-angiotensin system inhibition and cardiac and renal alteration induced by a high sodium diet in rat].
Rugale C; Jover B; Mimran A
Arch Mal Coeur Vaiss; 2006; 99(7-8):718-21. PubMed ID: 17061451
[TBL] [Abstract][Full Text] [Related]
34. Hemodynamic effects of phosphodiesterase 5 and angiotensin-converting enzyme inhibition alone or in combination in conscious SHR.
Gardiner SM; March JE; Kemp PA; Ballard SA; Hawkeswood E; Hughes B; Bennett T
J Pharmacol Exp Ther; 2005 Jan; 312(1):265-71. PubMed ID: 15452190
[TBL] [Abstract][Full Text] [Related]
35. Phosphate restriction significantly reduces mortality in uremic rats with established vascular calcification.
Finch JL; Lee DH; Liapis H; Ritter C; Zhang S; Suarez E; Ferder L; Slatopolsky E
Kidney Int; 2013 Dec; 84(6):1145-53. PubMed ID: 24107846
[TBL] [Abstract][Full Text] [Related]
36. [Either calcium carbonate or sevelamer decreases urinary oxalate excretion in chronic renal failure patients].
Caravaca F; Ruiz AB; Escola JM; Hernández Gallego R; Cerezo I; Fernández N; Barroso S; Martín MV
Nefrologia; 2007; 27(4):466-71. PubMed ID: 17944584
[TBL] [Abstract][Full Text] [Related]
37. Optimising the treatment of hyperphosphatemia and vascular calcification in chronic kidney disease.
Cozzolino M; Brancaccio D
Expert Opin Emerg Drugs; 2007 Sep; 12(3):341-3. PubMed ID: 17874964
[TBL] [Abstract][Full Text] [Related]
38. Vitamin D receptor agonist VS-105 improves cardiac function in the presence of enalapril in 5/6 nephrectomized rats.
Wu-Wong JR; Chen YW; Wessale JL
Am J Physiol Renal Physiol; 2015 Feb; 308(4):F309-19. PubMed ID: 25503724
[TBL] [Abstract][Full Text] [Related]
39. Enalapril and losartan restored blood pressure and vascular reactivity in intrauterine undernourished rats.
Ceravolo GS; Franco MC; Carneiro-Ramos MS; Barreto-Chaves ML; Tostes RC; Nigro D; Fortes ZB; Carvalho MH
Life Sci; 2007 Jan; 80(8):782-7. PubMed ID: 17161436
[TBL] [Abstract][Full Text] [Related]
40. Comparison of sevelamer hydrochloride and sevelamer carbonate: risk of metabolic acidosis and clinical implications.
Pai AB; Shepler BM
Pharmacotherapy; 2009 May; 29(5):554-61. PubMed ID: 19397463
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
